Anesthetic Regimens with Short-acting Opioids for Tight Intraoperative Control: A Case-based e-Newsletter

Release Date: June 24, 2015
Expiration Date: June 24, 2016

Faculty Editor

Adam Levine, MD
Professor of Anesthesiology, Otolaryngology, Structural and Chemical Biology
Icahn School of Medicine at Mount Sinai
Program Director
Residency Training Program
Department of Anesthesiology
Vice Chair for Education
Mount Sinai Health System
New York, New York

Program Overview

General anesthesia is meant for the patient who requires a controlled, reversible state of unconsciousness for surgical purposes. Significant advances in monitoring, safety systems, and the pharmacodynamic and pharmacokinetic profiles of anesthetic agents have contributed to improvements in the safety and effectiveness of general anesthesia. Even with these advances, safe and effective anesthetic practice would not be possible without highly-educated and well-trained anesthesia professionals.

This program will review important considerations for general anesthesia and opportunities for improving perioperative patient management by using a case-based format. Specifically, the use of opioid-based anesthesia will be discussed.

Target Audience

This educational initiative has been designed for anesthesia professionals involved in the management of patients undergoing procedures that require general anesthesia.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Delineate the pharmacokinetic profiles of short-acting opioids for general anesthesia
  • Describe the need to be able adjust short-acting opioids according to intraoperative patient responses
  • Evaluate the impact that opioid-based anesthesia regimens have on recovery times

Directions to Learner

There are no fees for participating and receiving CME credit for this activity. During the period June 24, 2015 through June 24, 2016, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest by recording the best answer to each question in the answer key on the evaluation form
  • Complete the evaluation form

A statement of credit will be issued upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. Your statement of credit will be sent to you within 4 weeks.



Accreditation Council for Continuing Medical Education Accreditation Statement

Integrity Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Integrity Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest (COI)

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The following faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Adam Levine, MD
Consultant: Mylan
Speaker: Mylan
Royalty: Spring Business and Science

Patima Tanapat, PhD, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Mylan, Inc. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc. and Mylan, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Privacy Policy

When you participate in an online educational activity sponsored by Integrity CE, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and...(continued)

Minimum System Requirements

Windows XP, Windows 2000, Windows Vista, and Windows 7
Intel Pentium 4, 2.33 + GHz (or equivalent)
Adobe® Flash® Player 10
For optimal performance, the use of Internet Explorer is not recommended.

Mac OS X v10.4 or later
1.8GHz or faster (or equivalent)
Intel Core Duo 1.33GHz or faster (or equivalent)
Adobe® Flash® Player 10

Click here for more information on minimum system requirements.


The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

begin pretest


 Sponsored by Integrity Continuing Education, Inc.
Supported by an educational grant from Mylan, Inc.